Dr Reddy's Labs launches generic injection indicated for abortion in US
The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said in a filing to BSE.
Why Dr D feels an apology won't help Boris Johnson
Johnson isn't guilty of racism, but of spasms of incorrectitude.
Share market update: Pharma shares up; Cipla gains 1%
The Nifty Pharma index was trading 0.14 per cent up at 8055.95.
Share market update: Nifty Pharma index dips; Glenmark Pharma down 2%
The Nifty Pharma index was trading 0.71 per cent down at 8131.70.
Share market update: Nifty Pharma index dips; Dr. Reddy's Lab down 2%
The Nifty Pharma index was trading 0.37 per cent down at 8243.
Buy Dr. Reddy's Laboratories, price target Rs 3,060: Sagar Doshi
The analyst suggested a stoploss at Rs 2920.
Ask Dr. D: Prince Andrew wants to know how he can escape the Jeffrey Epstein scandal
Dr. D gives Prince Andrew a much-needed reality check.
Share market update: 14 stocks hit 52-week highs on NSE
Overall, 43 shares were trading in green in Nifty50 index, while 6 were trading in the red.
Chinese strategy: Dr Reddy's outsources part manufacturing to local parties
The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year, the official said. The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's, the official further said.
Analyst Calls: Bandhan Bank, NHPC, Gail, Dr Reddy's Lab
JM Financial has maintained its buy rating on Bandhan Bank with a target price of Rs 710.
Manmohan Singh hopes NCP-Shiv Sena-Congress to form govt in Maharashtra
On being asked if NCP-Shiv Sena-Congress will be able to form a government in Maharashtra, former prime minster Dr. Manmohan Singh said, “I ...
SBI Cap Securities upgrades Dr Reddy's Labs to buy, target price Rs 3,200
Buy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3200.0 .
Share market update: Nifty Pharma index up; Dr. Reddy's Lab rises 1%
The Nifty Pharma index was trading 0.14 per cent up at 8118.65 around 10:42 am.
Dr Reddy's forays into nutrition segment; launches diabetic-friendly drink
It is a first-of-its-kind under Dr Reddy's nutrition portfolio and clinically proven to help manage blood glucose levels among Indian patients. The brand 'Celevida' is derived from two words 'Celebration' and 'Vida', which means 'Celebrate Life'. It is available in two flavours Kesar Elachi and Chocolate, which are taste tested with over 300 diabetics and prediabetics, it said.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service